Literature DB >> 9738657

Gangliosides of monocyte-derived macrophages of adults with advanced HIV infection show reduced surface accessibility.

C S Berenson1, M A Gallery, M S Katari, E W Foster, M A Pattoli.   

Abstract

Gangliosides of macrophages are potent immunoregulatory molecules. A monoclonal antibody directed at human macrophage gangliosides (25F4) inhibits macrophage migration with relative specificity. Recent reports suggested that greater expression of G(M1) in mononuclear cells accompanies advanced HIV infection, although others failed to demonstrate any differences in vitro. We purified gangliosides from blood monocyte-derived macrophages obtained from HIV-infected adults. Densitometric analysis of chromatograms demonstrated no differences in relative quantities of any macrophage gangliosides among all HIV-positive and -negative donors. Antibody 25F4 showed equivalent ELISA reactivity with purified macrophage gangliosides of HIV-positive and -negative donors. However, intact macrophages of HIV donors with CD4+ cell counts <200/mm3 showed impaired immunofluorescent surface expression of the 25F4 epitope and concomitant loss of migration inhibitory responsiveness. Thus, although relative content is unchanged, macrophage gangliosides become surface-inaccessible in adults with advanced HIV infection. Our data provide further evidence that dysregulation of glycosphingolipid metabolism in HIV-1 infection contributes to immune dysfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738657     DOI: 10.1002/jlb.64.3.311

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  1 in total

1.  Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.

Authors:  Charles S Berenson; Catherine T Wrona; Lori J Grove; Jane Maloney; Mary Alice Garlipp; Paul K Wallace; Carleton C Stewart; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2006-03-30       Impact factor: 21.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.